TrialBreast cancer research and treatment2015

Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial.

Javier Cortes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.